Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. Ying
OA08 Efficacy and Safety of Sintilimab Combined With 1st Line Chemotherapy in Advanced Squamous Cell Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
The Stevens Flood Advisory System: Operational H3E Flood Forecasts for the Greater New York / New Jersey Metropolitan Region
International Journal of Safety and Security Engineering
Quality
Reliability
Safety
Risk
Environmental Science
Related publications
P027 Efficacy and Safety of Bevacizumab Combined With Chemotherapy for Second - Line and Above in Non - Squamous Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Efficacy and Safety of Icotinib as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Bevacizumab Combination Chemotherapy in Clinical Practice for Advanced Non-Squamous Non-Small Cell Lung Cancer
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer
BMJ
P025 Which Is the Optimal Immunotherapy for Advanced Non-Squamous Non-Small-Cell Lung Cancer in Combination With Chemotherapy?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.01-94 Safety and Efficacy of First-Line Pemetrexed Versus Bevacizumab-Containing Regimens in Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.01-70 Meta-Analysis of Metformin in Combination With Platinum Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.13-21 Clinical Efficacy and Safety of Apatinib Combined With EGFR - TKIs in Advanced Non-Small Cell Lung Cancer With EGFR - TKIs Resistance
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Cost-Effectiveness of First-Line Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer Unsuitable for Chemotherapy
BMJ Open
Medicine